CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
We are very excited to launch our new website! Please take a few moments to click around and explore...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...